Ashland may be worth low/mid-$90/shr in takeover - analyst
A pauta traz uma atualização relevante e serve como base para a cobertura editorial. O recorte ajuda a contextualizar a pauta dentro de Finanças.
Notícias
Acompanhe as Notícias da Recifes
Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.
Apple’s stock could underperform, especially without an ‘all-glass’ iPhone, this analyst w
A Jefferies analyst says that it may be harder than it looks for Apple to roll out dramatically more expensive devices in a bid to boost profitability.
Why Netanyahu’s ‘coup’ against Gaza plan risks endless war
The Israeli leader’s rejection of a US-led roadmap threatens to entrench a state of conflict, analysts say. O recorte ajuda a contextualizar a pauta dentro de Geral.
These analysts say Elon Musk’s ambitious AI plans for SpaceX should be taken seriously, th
If Elon Musk can expand its compute capacity swiftly, Microsoft could be perfectly positioned to monetize this “one-in-a-generation opportunity”
Where does Iran stand on Saudi-Pakistan-Turkiye pact?
Iran not immediately threatened by pact, analysts say, with officials focusing on aspect of diminishing US role. O recorte ajuda a contextualizar a pauta dentro de Geral.
Solar tariffs are major boost for First Solar, analysts say
A pauta traz uma atualização relevante e serve como base para a cobertura editorial. O recorte ajuda a contextualizar a pauta dentro de Finanças.
Doximity’s stock skyrockets 50% on medical AI excitement. Can the rally last?
While one analyst thinks Doximity has a compelling AI opportunity, another worries that the company could cannibalize its core business of medical networking.
An AstraZeneca, Bristol Myers Squibb merger could create a cancer-drug giant, but analysts
AstraZeneca shares were slumping while Bristol-Myers Squibb’s stock was jumping on Monday on reported deal talks. But the big question is why these two pharmaceutical giants would want to come together in the first place.
3 reasons AMD’s stock is falling in the face of its latest earnings report
Analysts noted that the company delivered muted upside with its results, underwhelmed some investors with its margin outlook and was simply up against high expectations.
Sandisk is falling after earnings. Here’s what Wall Street says.
Sandisk stock slumped 9% in premarket trade on Thursday after the maker of NAND flash chips issued guidance that disappointed investors. Here’s what analysts are saying.
Chipotle’s stock extends its declines, but analysts aren’t sweating the jalapeno scare
“History has repeatedly shown that the sales impact of foodborne illness tends to be fleeting for restaurants,” one analyst noted.
5 big analyst AI moves: Pullback in this stock is an ’enhanced buying opportunity’
A pauta traz uma atualização relevante e serve como base para a cobertura editorial. O recorte ajuda a contextualizar a pauta dentro de Investimentos.